Dunlop A. Sinclair sells Apellis (APLS) shares worth $713k
NeutralFinancial Markets

Dunlop A. Sinclair has sold shares of Apellis Pharmaceuticals, amounting to $713,000. This transaction is significant as it reflects Sinclair's investment strategy and could influence market perceptions of Apellis. Investors often watch such sales closely, as they can indicate confidence or concerns about a company's future performance.
— Curated by the World Pulse Now AI Editorial System